Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Neurobiology of Aging|November 27, 2010
Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic miceNolwen L Rey, Daniel Jardanhazi-Kurutz, Dick Terwel, et al.
Alzheimer'S Research & Therapy|February 28, 2018
Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's diseaseFrederic Brosseron, Andreas Traschütz, Catherine N Widmann, et al.
Thrombosis and Haemostasis|September 12, 2014
Effects of dark chocolate consumption on the prothrombotic response to acute psychosocial stress in healthy menR von Känel, R E Meister, M Stutz, et al.
The Journal of Clinical Investigation|December 16, 2014
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease modelMarius Krauthausen, Markus P Kummer, Julian Zimmermann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 13, 2011
Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosisDick Terwel, Knut R Steffensen, Philip B Verghese, et al.
Alzheimer'S Research & Therapy|May 3, 2013
Targeting norepinephrine in mild cognitive impairment and Alzheimer's diseaseTermpanit Chalermpalanupap, Becky Kinkead, William T Hu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2009
NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficitsMarc Weberpals, Michael Hermes, S Hermann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 11, 2012
Mrp14 deficiency ameliorates amyloid β burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processingMarkus P Kummer, Thomas Vogl, Daisy Axt, et al.
Current Alzheimer Research|February 25, 2011
Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer's diseaseM T Heneka, M P Kummer, S Weggen, et al.
Pageof 7